Global Female Oral Contraceptives Supply, Demand and Key Producers, 2024-2030

Description

The global Female Oral Contraceptives market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report studies the global Female Oral Contraceptives production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Female Oral Contraceptives, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Female Oral Contraceptives that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Female Oral Contraceptives total production and demand, 2019-2030, (K Units)
Global Female Oral Contraceptives total production value, 2019-2030, (USD Million)
Global Female Oral Contraceptives production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Female Oral Contraceptives consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Female Oral Contraceptives domestic production, consumption, key domestic manufacturers and share
Global Female Oral Contraceptives production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Female Oral Contraceptives production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Female Oral Contraceptives production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).

This reports profiles key players in the global Female Oral Contraceptives market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer, Janssen Global Services, Allergan,plc (Actavis), Teva Pharmaceutical, Piramal Enterprises, Pfizer, Merck, Mankind Pharma and Syzygy Healthcare, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Female Oral Contraceptives market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Female Oral Contraceptives Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Female Oral Contraceptives Market, Segmentation by Type
    Combination Pill
    Progestin-only Pill
    Continuous Use Pill

Global Female Oral Contraceptives Market, Segmentation by Application
    Online Sales
    Offline Sales

Companies Profiled:
    Bayer
    Janssen Global Services
    Allergan,plc (Actavis)
    Teva Pharmaceutical
    Piramal Enterprises
    Pfizer
    Merck
    Mankind Pharma
    Syzygy Healthcare
    Ferring B.V

Key Questions Answered
1. How big is the global Female Oral Contraceptives market?
2. What is the demand of the global Female Oral Contraceptives market?
3. What is the year over year growth of the global Female Oral Contraceptives market?
4. What is the production and production value of the global Female Oral Contraceptives market?
5. Who are the key producers in the global Female Oral Contraceptives market?

Table of Contents

1 Supply Summary
    1.1 Female Oral Contraceptives Introduction
    1.2 World Female Oral Contraceptives Supply & Forecast
        1.2.1 World Female Oral Contraceptives Production Value (2019 & 2023 & 2030)
        1.2.2 World Female Oral Contraceptives Production (2019-2030)
        1.2.3 World Female Oral Contraceptives Pricing Trends (2019-2030)
    1.3 World Female Oral Contraceptives Production by Region (Based on Production Site)
        1.3.1 World Female Oral Contraceptives Production Value by Region (2019-2030)
        1.3.2 World Female Oral Contraceptives Production by Region (2019-2030)
        1.3.3 World Female Oral Contraceptives Average Price by Region (2019-2030)
        1.3.4 North America Female Oral Contraceptives Production (2019-2030)
        1.3.5 Europe Female Oral Contraceptives Production (2019-2030)
        1.3.6 China Female Oral Contraceptives Production (2019-2030)
        1.3.7 Japan Female Oral Contraceptives Production (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Female Oral Contraceptives Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Female Oral Contraceptives Major Market Trends

2 Demand Summary
    2.1 World Female Oral Contraceptives Demand (2019-2030)
    2.2 World Female Oral Contraceptives Consumption by Region
        2.2.1 World Female Oral Contraceptives Consumption by Region (2019-2024)
        2.2.2 World Female Oral Contraceptives Consumption Forecast by Region (2025-2030)
    2.3 United States Female Oral Contraceptives Consumption (2019-2030)
    2.4 China Female Oral Contraceptives Consumption (2019-2030)
    2.5 Europe Female Oral Contraceptives Consumption (2019-2030)
    2.6 Japan Female Oral Contraceptives Consumption (2019-2030)
    2.7 South Korea Female Oral Contraceptives Consumption (2019-2030)
    2.8 ASEAN Female Oral Contraceptives Consumption (2019-2030)
    2.9 India Female Oral Contraceptives Consumption (2019-2030)

3 World Female Oral Contraceptives Manufacturers Competitive Analysis
    3.1 World Female Oral Contraceptives Production Value by Manufacturer (2019-2024)
    3.2 World Female Oral Contraceptives Production by Manufacturer (2019-2024)
    3.3 World Female Oral Contraceptives Average Price by Manufacturer (2019-2024)
    3.4 Female Oral Contraceptives Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Female Oral Contraceptives Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Female Oral Contraceptives in 2023
        3.5.3 Global Concentration Ratios (CR8) for Female Oral Contraceptives in 2023
    3.6 Female Oral Contraceptives Market: Overall Company Footprint Analysis
        3.6.1 Female Oral Contraceptives Market: Region Footprint
        3.6.2 Female Oral Contraceptives Market: Company Product Type Footprint
        3.6.3 Female Oral Contraceptives Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Female Oral Contraceptives Production Value Comparison
        4.1.1 United States VS China: Female Oral Contraceptives Production Value Comparison (2019 & 2023 & 2030)
        4.1.2 United States VS China: Female Oral Contraceptives Production Value Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States VS China: Female Oral Contraceptives Production Comparison
        4.2.1 United States VS China: Female Oral Contraceptives Production Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Female Oral Contraceptives Production Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States VS China: Female Oral Contraceptives Consumption Comparison
        4.3.1 United States VS China: Female Oral Contraceptives Consumption Comparison (2019 & 2023 & 2030)
        4.3.2 United States VS China: Female Oral Contraceptives Consumption Market Share Comparison (2019 & 2023 & 2030)
    4.4 United States Based Female Oral Contraceptives Manufacturers and Market Share, 2019-2024
        4.4.1 United States Based Female Oral Contraceptives Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Female Oral Contraceptives Production Value (2019-2024)
        4.4.3 United States Based Manufacturers Female Oral Contraceptives Production (2019-2024)
    4.5 China Based Female Oral Contraceptives Manufacturers and Market Share
        4.5.1 China Based Female Oral Contraceptives Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Female Oral Contraceptives Production Value (2019-2024)
        4.5.3 China Based Manufacturers Female Oral Contraceptives Production (2019-2024)
    4.6 Rest of World Based Female Oral Contraceptives Manufacturers and Market Share, 2019-2024
        4.6.1 Rest of World Based Female Oral Contraceptives Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Female Oral Contraceptives Production Value (2019-2024)
        4.6.3 Rest of World Based Manufacturers Female Oral Contraceptives Production (2019-2024)

5 Market Analysis by Type
    5.1 World Female Oral Contraceptives Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Combination Pill
        5.2.2 Progestin-only Pill
        5.2.3 Continuous Use Pill
    5.3 Market Segment by Type
        5.3.1 World Female Oral Contraceptives Production by Type (2019-2030)
        5.3.2 World Female Oral Contraceptives Production Value by Type (2019-2030)
        5.3.3 World Female Oral Contraceptives Average Price by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Female Oral Contraceptives Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Online Sales
        6.2.2 Offline Sales
    6.3 Market Segment by Application
        6.3.1 World Female Oral Contraceptives Production by Application (2019-2030)
        6.3.2 World Female Oral Contraceptives Production Value by Application (2019-2030)
        6.3.3 World Female Oral Contraceptives Average Price by Application (2019-2030)

7 Company Profiles
    7.1 Bayer
        7.1.1 Bayer Details
        7.1.2 Bayer Major Business
        7.1.3 Bayer Female Oral Contraceptives Product and Services
        7.1.4 Bayer Female Oral Contraceptives Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.1.5 Bayer Recent Developments/Updates
        7.1.6 Bayer Competitive Strengths & Weaknesses
    7.2 Janssen Global Services
        7.2.1 Janssen Global Services Details
        7.2.2 Janssen Global Services Major Business
        7.2.3 Janssen Global Services Female Oral Contraceptives Product and Services
        7.2.4 Janssen Global Services Female Oral Contraceptives Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.2.5 Janssen Global Services Recent Developments/Updates
        7.2.6 Janssen Global Services Competitive Strengths & Weaknesses
    7.3 Allergan,plc (Actavis)
        7.3.1 Allergan,plc (Actavis) Details
        7.3.2 Allergan,plc (Actavis) Major Business
        7.3.3 Allergan,plc (Actavis) Female Oral Contraceptives Product and Services
        7.3.4 Allergan,plc (Actavis) Female Oral Contraceptives Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.3.5 Allergan,plc (Actavis) Recent Developments/Updates
        7.3.6 Allergan,plc (Actavis) Competitive Strengths & Weaknesses
    7.4 Teva Pharmaceutical
        7.4.1 Teva Pharmaceutical Details
        7.4.2 Teva Pharmaceutical Major Business
        7.4.3 Teva Pharmaceutical Female Oral Contraceptives Product and Services
        7.4.4 Teva Pharmaceutical Female Oral Contraceptives Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.4.5 Teva Pharmaceutical Recent Developments/Updates
        7.4.6 Teva Pharmaceutical Competitive Strengths & Weaknesses
    7.5 Piramal Enterprises
        7.5.1 Piramal Enterprises Details
        7.5.2 Piramal Enterprises Major Business
        7.5.3 Piramal Enterprises Female Oral Contraceptives Product and Services
        7.5.4 Piramal Enterprises Female Oral Contraceptives Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.5.5 Piramal Enterprises Recent Developments/Updates
        7.5.6 Piramal Enterprises Competitive Strengths & Weaknesses
    7.6 Pfizer
        7.6.1 Pfizer Details
        7.6.2 Pfizer Major Business
        7.6.3 Pfizer Female Oral Contraceptives Product and Services
        7.6.4 Pfizer Female Oral Contraceptives Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.6.5 Pfizer Recent Developments/Updates
        7.6.6 Pfizer Competitive Strengths & Weaknesses
    7.7 Merck
        7.7.1 Merck Details
        7.7.2 Merck Major Business
        7.7.3 Merck Female Oral Contraceptives Product and Services
        7.7.4 Merck Female Oral Contraceptives Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.7.5 Merck Recent Developments/Updates
        7.7.6 Merck Competitive Strengths & Weaknesses
    7.8 Mankind Pharma
        7.8.1 Mankind Pharma Details
        7.8.2 Mankind Pharma Major Business
        7.8.3 Mankind Pharma Female Oral Contraceptives Product and Services
        7.8.4 Mankind Pharma Female Oral Contraceptives Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.8.5 Mankind Pharma Recent Developments/Updates
        7.8.6 Mankind Pharma Competitive Strengths & Weaknesses
    7.9 Syzygy Healthcare
        7.9.1 Syzygy Healthcare Details
        7.9.2 Syzygy Healthcare Major Business
        7.9.3 Syzygy Healthcare Female Oral Contraceptives Product and Services
        7.9.4 Syzygy Healthcare Female Oral Contraceptives Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.9.5 Syzygy Healthcare Recent Developments/Updates
        7.9.6 Syzygy Healthcare Competitive Strengths & Weaknesses
    7.10 Ferring B.V
        7.10.1 Ferring B.V Details
        7.10.2 Ferring B.V Major Business
        7.10.3 Ferring B.V Female Oral Contraceptives Product and Services
        7.10.4 Ferring B.V Female Oral Contraceptives Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.10.5 Ferring B.V Recent Developments/Updates
        7.10.6 Ferring B.V Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Female Oral Contraceptives Industry Chain
    8.2 Female Oral Contraceptives Upstream Analysis
        8.2.1 Female Oral Contraceptives Core Raw Materials
        8.2.2 Main Manufacturers of Female Oral Contraceptives Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Female Oral Contraceptives Production Mode
    8.6 Female Oral Contraceptives Procurement Model
    8.7 Female Oral Contraceptives Industry Sales Model and Sales Channels
        8.7.1 Female Oral Contraceptives Sales Model
        8.7.2 Female Oral Contraceptives Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Female Oral Contraceptives Production Value by Region (2019, 2023 and 2030) & (USD Million)
    Table 2. World Female Oral Contraceptives Production Value by Region (2019-2024) & (USD Million)
    Table 3. World Female Oral Contraceptives Production Value by Region (2025-2030) & (USD Million)
    Table 4. World Female Oral Contraceptives Production Value Market Share by Region (2019-2024)
    Table 5. World Female Oral Contraceptives Production Value Market Share by Region (2025-2030)
    Table 6. World Female Oral Contraceptives Production by Region (2019-2024) & (K Units)
    Table 7. World Female Oral Contraceptives Production by Region (2025-2030) & (K Units)
    Table 8. World Female Oral Contraceptives Production Market Share by Region (2019-2024)
    Table 9. World Female Oral Contraceptives Production Market Share by Region (2025-2030)
    Table 10. World Female Oral Contraceptives Average Price by Region (2019-2024) & (US$/Unit)
    Table 11. World Female Oral Contraceptives Average Price by Region (2025-2030) & (US$/Unit)
    Table 12. Female Oral Contraceptives Major Market Trends
    Table 13. World Female Oral Contraceptives Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
    Table 14. World Female Oral Contraceptives Consumption by Region (2019-2024) & (K Units)
    Table 15. World Female Oral Contraceptives Consumption Forecast by Region (2025-2030) & (K Units)
    Table 16. World Female Oral Contraceptives Production Value by Manufacturer (2019-2024) & (USD Million)
    Table 17. Production Value Market Share of Key Female Oral Contraceptives Producers in 2023
    Table 18. World Female Oral Contraceptives Production by Manufacturer (2019-2024) & (K Units)
    Table 19. Production Market Share of Key Female Oral Contraceptives Producers in 2023
    Table 20. World Female Oral Contraceptives Average Price by Manufacturer (2019-2024) & (US$/Unit)
    Table 21. Global Female Oral Contraceptives Company Evaluation Quadrant
    Table 22. World Female Oral Contraceptives Industry Rank of Major Manufacturers, Based on Production Value in 2023
    Table 23. Head Office and Female Oral Contraceptives Production Site of Key Manufacturer
    Table 24. Female Oral Contraceptives Market: Company Product Type Footprint
    Table 25. Female Oral Contraceptives Market: Company Product Application Footprint
    Table 26. Female Oral Contraceptives Competitive Factors
    Table 27. Female Oral Contraceptives New Entrant and Capacity Expansion Plans
    Table 28. Female Oral Contraceptives Mergers & Acquisitions Activity
    Table 29. United States VS China Female Oral Contraceptives Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 30. United States VS China Female Oral Contraceptives Production Comparison, (2019 & 2023 & 2030) & (K Units)
    Table 31. United States VS China Female Oral Contraceptives Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
    Table 32. United States Based Female Oral Contraceptives Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Female Oral Contraceptives Production Value, (2019-2024) & (USD Million)
    Table 34. United States Based Manufacturers Female Oral Contraceptives Production Value Market Share (2019-2024)
    Table 35. United States Based Manufacturers Female Oral Contraceptives Production (2019-2024) & (K Units)
    Table 36. United States Based Manufacturers Female Oral Contraceptives Production Market Share (2019-2024)
    Table 37. China Based Female Oral Contraceptives Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Female Oral Contraceptives Production Value, (2019-2024) & (USD Million)
    Table 39. China Based Manufacturers Female Oral Contraceptives Production Value Market Share (2019-2024)
    Table 40. China Based Manufacturers Female Oral Contraceptives Production (2019-2024) & (K Units)
    Table 41. China Based Manufacturers Female Oral Contraceptives Production Market Share (2019-2024)
    Table 42. Rest of World Based Female Oral Contraceptives Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Female Oral Contraceptives Production Value, (2019-2024) & (USD Million)
    Table 44. Rest of World Based Manufacturers Female Oral Contraceptives Production Value Market Share (2019-2024)
    Table 45. Rest of World Based Manufacturers Female Oral Contraceptives Production (2019-2024) & (K Units)
    Table 46. Rest of World Based Manufacturers Female Oral Contraceptives Production Market Share (2019-2024)
    Table 47. World Female Oral Contraceptives Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 48. World Female Oral Contraceptives Production by Type (2019-2024) & (K Units)
    Table 49. World Female Oral Contraceptives Production by Type (2025-2030) & (K Units)
    Table 50. World Female Oral Contraceptives Production Value by Type (2019-2024) & (USD Million)
    Table 51. World Female Oral Contraceptives Production Value by Type (2025-2030) & (USD Million)
    Table 52. World Female Oral Contraceptives Average Price by Type (2019-2024) & (US$/Unit)
    Table 53. World Female Oral Contraceptives Average Price by Type (2025-2030) & (US$/Unit)
    Table 54. World Female Oral Contraceptives Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 55. World Female Oral Contraceptives Production by Application (2019-2024) & (K Units)
    Table 56. World Female Oral Contraceptives Production by Application (2025-2030) & (K Units)
    Table 57. World Female Oral Contraceptives Production Value by Application (2019-2024) & (USD Million)
    Table 58. World Female Oral Contraceptives Production Value by Application (2025-2030) & (USD Million)
    Table 59. World Female Oral Contraceptives Average Price by Application (2019-2024) & (US$/Unit)
    Table 60. World Female Oral Contraceptives Average Price by Application (2025-2030) & (US$/Unit)
    Table 61. Bayer Basic Information, Manufacturing Base and Competitors
    Table 62. Bayer Major Business
    Table 63. Bayer Female Oral Contraceptives Product and Services
    Table 64. Bayer Female Oral Contraceptives Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 65. Bayer Recent Developments/Updates
    Table 66. Bayer Competitive Strengths & Weaknesses
    Table 67. Janssen Global Services Basic Information, Manufacturing Base and Competitors
    Table 68. Janssen Global Services Major Business
    Table 69. Janssen Global Services Female Oral Contraceptives Product and Services
    Table 70. Janssen Global Services Female Oral Contraceptives Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 71. Janssen Global Services Recent Developments/Updates
    Table 72. Janssen Global Services Competitive Strengths & Weaknesses
    Table 73. Allergan,plc (Actavis) Basic Information, Manufacturing Base and Competitors
    Table 74. Allergan,plc (Actavis) Major Business
    Table 75. Allergan,plc (Actavis) Female Oral Contraceptives Product and Services
    Table 76. Allergan,plc (Actavis) Female Oral Contraceptives Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 77. Allergan,plc (Actavis) Recent Developments/Updates
    Table 78. Allergan,plc (Actavis) Competitive Strengths & Weaknesses
    Table 79. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 80. Teva Pharmaceutical Major Business
    Table 81. Teva Pharmaceutical Female Oral Contraceptives Product and Services
    Table 82. Teva Pharmaceutical Female Oral Contraceptives Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 83. Teva Pharmaceutical Recent Developments/Updates
    Table 84. Teva Pharmaceutical Competitive Strengths & Weaknesses
    Table 85. Piramal Enterprises Basic Information, Manufacturing Base and Competitors
    Table 86. Piramal Enterprises Major Business
    Table 87. Piramal Enterprises Female Oral Contraceptives Product and Services
    Table 88. Piramal Enterprises Female Oral Contraceptives Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 89. Piramal Enterprises Recent Developments/Updates
    Table 90. Piramal Enterprises Competitive Strengths & Weaknesses
    Table 91. Pfizer Basic Information, Manufacturing Base and Competitors
    Table 92. Pfizer Major Business
    Table 93. Pfizer Female Oral Contraceptives Product and Services
    Table 94. Pfizer Female Oral Contraceptives Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 95. Pfizer Recent Developments/Updates
    Table 96. Pfizer Competitive Strengths & Weaknesses
    Table 97. Merck Basic Information, Manufacturing Base and Competitors
    Table 98. Merck Major Business
    Table 99. Merck Female Oral Contraceptives Product and Services
    Table 100. Merck Female Oral Contraceptives Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 101. Merck Recent Developments/Updates
    Table 102. Merck Competitive Strengths & Weaknesses
    Table 103. Mankind Pharma Basic Information, Manufacturing Base and Competitors
    Table 104. Mankind Pharma Major Business
    Table 105. Mankind Pharma Female Oral Contraceptives Product and Services
    Table 106. Mankind Pharma Female Oral Contraceptives Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 107. Mankind Pharma Recent Developments/Updates
    Table 108. Mankind Pharma Competitive Strengths & Weaknesses
    Table 109. Syzygy Healthcare Basic Information, Manufacturing Base and Competitors
    Table 110. Syzygy Healthcare Major Business
    Table 111. Syzygy Healthcare Female Oral Contraceptives Product and Services
    Table 112. Syzygy Healthcare Female Oral Contraceptives Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 113. Syzygy Healthcare Recent Developments/Updates
    Table 114. Ferring B.V Basic Information, Manufacturing Base and Competitors
    Table 115. Ferring B.V Major Business
    Table 116. Ferring B.V Female Oral Contraceptives Product and Services
    Table 117. Ferring B.V Female Oral Contraceptives Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 118. Global Key Players of Female Oral Contraceptives Upstream (Raw Materials)
    Table 119. Female Oral Contraceptives Typical Customers
    Table 120. Female Oral Contraceptives Typical Distributors
List of Figure
    Figure 1. Female Oral Contraceptives Picture
    Figure 2. World Female Oral Contraceptives Production Value: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Female Oral Contraceptives Production Value and Forecast (2019-2030) & (USD Million)
    Figure 4. World Female Oral Contraceptives Production (2019-2030) & (K Units)
    Figure 5. World Female Oral Contraceptives Average Price (2019-2030) & (US$/Unit)
    Figure 6. World Female Oral Contraceptives Production Value Market Share by Region (2019-2030)
    Figure 7. World Female Oral Contraceptives Production Market Share by Region (2019-2030)
    Figure 8. North America Female Oral Contraceptives Production (2019-2030) & (K Units)
    Figure 9. Europe Female Oral Contraceptives Production (2019-2030) & (K Units)
    Figure 10. China Female Oral Contraceptives Production (2019-2030) & (K Units)
    Figure 11. Japan Female Oral Contraceptives Production (2019-2030) & (K Units)
    Figure 12. Female Oral Contraceptives Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Female Oral Contraceptives Consumption (2019-2030) & (K Units)
    Figure 15. World Female Oral Contraceptives Consumption Market Share by Region (2019-2030)
    Figure 16. United States Female Oral Contraceptives Consumption (2019-2030) & (K Units)
    Figure 17. China Female Oral Contraceptives Consumption (2019-2030) & (K Units)
    Figure 18. Europe Female Oral Contraceptives Consumption (2019-2030) & (K Units)
    Figure 19. Japan Female Oral Contraceptives Consumption (2019-2030) & (K Units)
    Figure 20. South Korea Female Oral Contraceptives Consumption (2019-2030) & (K Units)
    Figure 21. ASEAN Female Oral Contraceptives Consumption (2019-2030) & (K Units)
    Figure 22. India Female Oral Contraceptives Consumption (2019-2030) & (K Units)
    Figure 23. Producer Shipments of Female Oral Contraceptives by Manufacturer Revenue ($MM) and Market Share (%): 2023
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Female Oral Contraceptives Markets in 2023
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Female Oral Contraceptives Markets in 2023
    Figure 26. United States VS China: Female Oral Contraceptives Production Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 27. United States VS China: Female Oral Contraceptives Production Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Female Oral Contraceptives Consumption Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. United States Based Manufacturers Female Oral Contraceptives Production Market Share 2023
    Figure 30. China Based Manufacturers Female Oral Contraceptives Production Market Share 2023
    Figure 31. Rest of World Based Manufacturers Female Oral Contraceptives Production Market Share 2023
    Figure 32. World Female Oral Contraceptives Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 33. World Female Oral Contraceptives Production Value Market Share by Type in 2023
    Figure 34. Combination Pill
    Figure 35. Progestin-only Pill
    Figure 36. Continuous Use Pill
    Figure 37. World Female Oral Contraceptives Production Market Share by Type (2019-2030)
    Figure 38. World Female Oral Contraceptives Production Value Market Share by Type (2019-2030)
    Figure 39. World Female Oral Contraceptives Average Price by Type (2019-2030) & (US$/Unit)
    Figure 40. World Female Oral Contraceptives Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 41. World Female Oral Contraceptives Production Value Market Share by Application in 2023
    Figure 42. Online Sales
    Figure 43. Offline Sales
    Figure 44. World Female Oral Contraceptives Production Market Share by Application (2019-2030)
    Figure 45. World Female Oral Contraceptives Production Value Market Share by Application (2019-2030)
    Figure 46. World Female Oral Contraceptives Average Price by Application (2019-2030) & (US$/Unit)
    Figure 47. Female Oral Contraceptives Industry Chain
    Figure 48. Female Oral Contraceptives Procurement Model
    Figure 49. Female Oral Contraceptives Sales Model
    Figure 50. Female Oral Contraceptives Sales Channels, Direct Sales, and Distribution
    Figure 51. Methodology
    Figure 52. Research Process and Data Source

Companies Mentioned

Bayer
Janssen Global Services
Allergan,plc (Actavis)
Teva Pharmaceutical
Piramal Enterprises
Pfizer
Merck
Mankind Pharma
Syzygy Healthcare
Ferring B.V